Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rapid Onsite Cytopathologic Evaluation for Improved Molecular Marker Testing Via Endobronchial Ultrasound Bronchoscopy - A Randomized Controlled Trial

NCT04945317 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT04945317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04945317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rapid Onsite Cytopathologic Evaluation for Improved Molecular Marker Testing Via Endobronchial Ultrasound Bronchoscopy - A Randomized Controlled Trial
Lead sponsor
Johns Hopkins University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
May 14, 2021
Completion date
December 31, 2026
Enrollment
349 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer (nsclc)